IT1399923B1 - Procedimento di preparazione di sali dell'acido (r) alfa-lipoico loro formulazione ed uso nelle composizioni farmaceutiche in forma di compresse che li contengono - Google Patents

Procedimento di preparazione di sali dell'acido (r) alfa-lipoico loro formulazione ed uso nelle composizioni farmaceutiche in forma di compresse che li contengono

Info

Publication number
IT1399923B1
IT1399923B1 ITMI2010A000831A ITMI20100831A IT1399923B1 IT 1399923 B1 IT1399923 B1 IT 1399923B1 IT MI2010A000831 A ITMI2010A000831 A IT MI2010A000831A IT MI20100831 A ITMI20100831 A IT MI20100831A IT 1399923 B1 IT1399923 B1 IT 1399923B1
Authority
IT
Italy
Prior art keywords
lipoic
tablets
alpha
formulation
salts
Prior art date
Application number
ITMI2010A000831A
Other languages
English (en)
Inventor
Massimiliano Borsa
Carlo Cantabene
Original Assignee
Cbb Net S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cbb Net S A filed Critical Cbb Net S A
Priority to ITMI2010A000831A priority Critical patent/IT1399923B1/it
Priority to EP11003836A priority patent/EP2386552A1/en
Publication of ITMI20100831A1 publication Critical patent/ITMI20100831A1/it
Application granted granted Critical
Publication of IT1399923B1 publication Critical patent/IT1399923B1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ITMI2010A000831A 2010-05-11 2010-05-11 Procedimento di preparazione di sali dell'acido (r) alfa-lipoico loro formulazione ed uso nelle composizioni farmaceutiche in forma di compresse che li contengono IT1399923B1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ITMI2010A000831A IT1399923B1 (it) 2010-05-11 2010-05-11 Procedimento di preparazione di sali dell'acido (r) alfa-lipoico loro formulazione ed uso nelle composizioni farmaceutiche in forma di compresse che li contengono
EP11003836A EP2386552A1 (en) 2010-05-11 2011-05-10 Process for the preparation of (R) a-lipoic acid salts, their formulation and use in pharmaceutical compositions, in form of tablets containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2010A000831A IT1399923B1 (it) 2010-05-11 2010-05-11 Procedimento di preparazione di sali dell'acido (r) alfa-lipoico loro formulazione ed uso nelle composizioni farmaceutiche in forma di compresse che li contengono

Publications (2)

Publication Number Publication Date
ITMI20100831A1 ITMI20100831A1 (it) 2011-11-12
IT1399923B1 true IT1399923B1 (it) 2013-05-09

Family

ID=43049425

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI2010A000831A IT1399923B1 (it) 2010-05-11 2010-05-11 Procedimento di preparazione di sali dell'acido (r) alfa-lipoico loro formulazione ed uso nelle composizioni farmaceutiche in forma di compresse che li contengono

Country Status (2)

Country Link
EP (1) EP2386552A1 (it)
IT (1) IT1399923B1 (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013115739A1 (en) * 2012-01-31 2013-08-08 Mahmut Bilgic Production method for formulations comprising comprising nateglinide and lipoic acid
US11407721B2 (en) 2013-02-19 2022-08-09 Amgen Inc. CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer
JOP20200296A1 (ar) * 2013-06-10 2017-06-16 Amgen Inc عمليات صنع وأشكال بلورية من mdm2 مثبط
CN105622571A (zh) * 2016-03-08 2016-06-01 苏州富士莱医药股份有限公司 一种r-硫辛酸氨基丁三醇盐的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2038733T3 (es) 1987-12-04 1993-08-01 Asta Medica Ag Procedimiento para preparar una solucion inyectable de la sal de acido tioctico con trometanol y/o aminoacidos basicos.
PT95826B (pt) 1989-11-09 1997-11-28 Asta Medica Ag Processo para a preparacao de composicoes farmaceuticas contendo como ingrediente activo acido r-alfa-liponico ou acido s-alfa-liponico
KR930005554B1 (ko) * 1991-02-08 1993-06-23 주식회사 금성사 액정 표시소자의 액정주입 장치 및 방법
DE4433764A1 (de) * 1994-09-22 1996-03-28 Asta Medica Ag Darreichungsformen enthaltend alpha-Liponsäure, feste Salze von R-Thioctsäure mit verbesserter Freisetzung und Bioverfügbarkeit
DE10137381A1 (de) * 2001-07-31 2003-02-13 Viatris Gmbh Neue Modifikationen des Trometamolsalzes der R-Thioctsäure sowie Verfahren zu ihrer Herstellung
WO2007149313A1 (en) * 2006-06-16 2007-12-27 Indigene Pharmaceuticals Inc. Metformin r-(+) lipoate as an antidiabetic agent for control of diabetic hyperglycemia and diabetic complications
WO2009137074A1 (en) * 2008-05-06 2009-11-12 Indigene Pharmaceuticals, Inc. Compositions and methods for treating diabetic ulcers
KR100935554B1 (ko) 2009-06-24 2010-01-07 주식회사 셀트리온제약 피페라진 다이티옥트산염 및 이를 포함하는 약제학적 조성물

Also Published As

Publication number Publication date
EP2386552A1 (en) 2011-11-16
ITMI20100831A1 (it) 2011-11-12

Similar Documents

Publication Publication Date Title
IL250259A0 (en) Preparations containing ursolic acid or its derivative and their uses
IL233282A (en) Crystalline Forms of 5- (2,6-Di-4-Morpholinyl-4-Pyrimidinyl) -4-Trifluoromethylpyridine-2-Amine Monohydrochloride
HU1000069D0 (en) New salts for the preparation of pharmaceutical composition
IL233200A0 (en) The history of alpha-boronic acid, its preparation and pharmaceutical preparations containing it
HK1182010A1 (en) Liquid pharmaceutical composition for the delivery of active ingredients
PL2398468T3 (pl) Kompozycje farmaceutyczne zawierające zasadę prasugrelu lub jej farmaceutycznie dopuszczalne kwasowe sole addycyjne i sposoby ich otrzymywania
IL222578A0 (en) Method for preparing pharmaceutical compositions intended for oral administration comprising one or more active ingredients and the compositions comprising same
HK1245139A1 (zh) 用於在局部給藥位點改進藥物組合物的滯留的組合物和方法
WO2012098562A3 (en) Liquid oral compositions of lanthanum salts
MX2013001919A (es) Producto para el cuidado bucal y metodos de uso y elaboracion del mismo
HK1218709A1 (zh) 新水楊酸衍生物、其藥學上可接受的鹽、其組合物以及其使用方法
IL230547A0 (en) Formulations of deoxycholic acid and saline
WO2012130820A3 (de) Isopentylester zur verwendung in kosmetischen, dermatologischen oder pharmazeutischen kompositionen
IL218137A (en) Annotated 4-Benzamido Benzoic Acid, Preparations Containing and Using It for the Preparation of Medicines
PL2582359T3 (pl) Stałe kompozycje w postaci proszków lub granulatów do podawania doustnego składników czynnych i sposoby ich otrzymywania
EP2576576A4 (en) HETEROCYCLYL-PYRIDINYL BASE PHOSPHONIC ACID, PHARMACEUTICALLY ALLOWED SALT, COMPOSITION, AND METHOD OF USE THEREOF
IL227024A (en) The 3 heteroarylamino propionic acid derivatives are converted into amino acids, a process for their preparation, their use in the preparation of medicinal preparations and as medical preparations containing them
ZA201500362B (en) Novel compound having ability to inhibit 11b-hsd1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient
IT1399923B1 (it) Procedimento di preparazione di sali dell'acido (r) alfa-lipoico loro formulazione ed uso nelle composizioni farmaceutiche in forma di compresse che li contengono
WO2012074830A3 (en) Modified release tranexamic acid formulation
PL2702060T3 (pl) Kwasowe addycyjne sole risperidonu i ich kompozycje farmaceutyczne
IN2014MN02156A (it)
PL2561876T3 (pl) Formulacje kwasu deoksycholowego i ich sole
ITMI20062254A1 (it) Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
BR112012016736A2 (pt) composição , formulação farmacêutica e uso da composição"